mumazuva achangopfuura, vatengi vakawanda vanobvunza semaglutide, chii?
regai zvione -
Semaglutide mushonga weantidiabetic unoshandiswa kurapa rudzi rwe2 chirwere cheshuga uye mushonga unorwisa kufutisa unoshandiswa kwenguva yakareba uremu manejimendi.Iyo peptide yakafanana nehomoni glucagon-like peptide-1 (GLP-1), yakagadziridzwa ne side cheni.
Inogona kupihwa ne subcutaneous jekiseni kana kutorwa nemuromo.
Inotengeswa pasi pezita rezita rekuti Ozempic uye Rybelsus yechirwere cheshuga, uye pasi pezita rekuti Wegovy yekurasikirwa uremu.
kuchena kuri sei?
test report inoratidza, yakakwira kwazvo prutiy 99.26%,
Zvishandiso zvekurapa
Semaglutide inoratidzwa sechidimbu chekudya uye kurovedza muviri kuvandudza glycemic control kune vanhu vakuru vane chirwere cheshuga 2.
Iyo yepamusoro-dose yekugadzira semaglutide inoratidzwa seyakagadziriswa yekudya uye kurovedza muviri kwenguva yakareba uremu manejimendi kune vanhu vakuru vane kufutisa (initial body mass index (BMI) ≥ 30 kg / m2) kana avo vanorema (yekutanga BMI ≥ 27 kg /m2) uye vane huremu humwechete hunoenderana nehuremu.
Migumisiro yakaipa
Semaglutide ndeye gcagon-yakafanana peptide-1 receptor agonist.
Migumisiro yakajairika inosanganisira kuda kurutsa, kurutsa, manyoka, kurwadziwa nemudumbu, uye kusvira.
chimwe chigadzirwa chakafanana
semaglutide
Tirzepatide
chitupa
Retatrutid
Liraglutide
kana uchida mamwe madetials ndapota ndizivise
Nguva yekutumira: May-22-2024